Thomas Kurian, CEO of Google Cloud, speaks at a cloud computing conference held by the company in 2019.
Michael Short | Bloomberg | Getty Images
Google Cloud on Monday announced new artificial intelligence-powered search capabilities that it said will help health-care workers quickly pull accurate clinical information from different types of medical records.
The health-care industry is home to troves of valuable information and data, but it can be challenging for clinicians to find since it’s often stored across multiple systems and formats. Google Cloud’s new search tool will allow doctors to pull information from clinical notes, scanned documents and electronic health records so it can be accessed in one place.
The company said the new capabilities will ultimately save health-care workers a significant amount of time and energy.
“While it should save time to be able to do that search, it should also prevent frustration on behalf of clinicians and [make] sure that they get to an answer easier,” Lisa O’Malley, senior director of product management for Cloud AI at Google Cloud told CNBC in an interview.
For instance, if doctors want to know about a patient’s history, they no longer need to read through their notes, faxes and electronic health records separately. Instead, they can search questions such as “What medications has this patient taken in the last 12 months?” and see the relevant information in one place.
Google’s new search capabilities can also be used for other crucial applications such as applying the correct billing codes and determining whether patients meet the criteria to enroll in a clinical trial, O’Malley said.
She added that the technology can cite and link to the original source of the information, which will come directly from an organization’s own internal data. This should help alleviate clinicians’ concerns that the AI might be hallucinating, or generating inaccurate responses.
Google Cloud headquarters in Sunnyvale, California.
Google Cloud
The search features will be especially valuable to health-care workers who are already burdened with staffing shortages and daunting amounts of clerical paperwork.
A study funded by the American Medical Association in 2016 found that for every hour a physician spent with a patient, they spent an additional two hours on administrative work. The study said physicians also tend to spend an additional one to two hours doing clerical work outside of working hours, which many in the industry refer to as “pajama time.”
In 2022, 53% of physicians reported that they were feeling burned out, up from 42% in 2018, according to a January survey from Medscape.
Google hopes its new search offerings will reduce the amount of time clinicians need to spend digging through additional records and databases.
“Anything that Google can do by applying our search technologies, our health-care technologies and research capabilities to make the journey of the clinicians and health-care providers and payers more quick, more efficient, saving them cost, I think ultimately benefits us as patients,” O’Malley said.
The new features will be offered to health and life sciences organizations through Google’s Vertex AI Search platform, which companies in other industries can already use to conduct searches across public websites, documents and other databases. The specific offering for health care builds on Google’s existing Healthcare API and Healthcare Data Engine products.
Aashima Gupta, global director of health care strategy and solutions at Google Cloud, said the new Vertex AI Search capabilities can integrate directly into a clinician’s workflow, which is of high importance for customers in the field.
The health-care industry has historically been more hesitant to embrace new technology, and adoption can be even harder if health-care workers find new solutions distracting or hard to work with. It’s something Gupta said Google has been paying close attention to.
“These are the workflows that the physicians and nurses live by day in and day out. You can’t be adding friction to it,” Gupta told CNBC in an interview. “We are very cautious of that — that we are respecting the surface they use, that the workflow doesn’t change, but yet they get the power of this technology.”
Customers can sign up for early access to Vertex AI Search for health care and life sciences starting Monday, but Google Cloud has already been testing the capabilities with health organizations such as Mayo Clinic, Hackensack Meridian Health and Highmark Health.
Mayo Clinic is not using the new Vertex AI Search tools in clinical care yet, said Cris Ross, Mayo’s chief information officer; it is starting with administrative use cases.
“We are curious, we’re enthusiastic, we’re also careful,” he told CNBC in an interview. “And we’re not going to put anything into patient care until it’s really ready to be in patient care.”
Down the line, Ross said, Mayo Clinic is looking to explore how Vertex AI Search tools could be used to help nurses summarize long surgical notes, sort through patients’ complex medical histories, and easily answer questions such as “What is the smoking status of this patient?” But for now, the organization is starting slow and examining where AI solutions like Google’s will be the most useful.
Richard Clarke, chief analytics officer at Highmark Health, said the initial reaction to the search tools at the organization has been “tremendous” and the company already has a backlog of more than 200 use-case ideas. But similar to Mayo Clinic, he said the challenge will be prioritizing where the technology can be most useful, building employees’ trust in it and deploying it at scale.
“This is still very early days, deployed with small teams with lots of support, really thinking about this,” Clarke told CNBC in an interview. “We haven’t gone big and wide yet, but all early signs say that this is going to be tremendously useful, and frankly, in many cases, transformational for us.”
Google Cloud does not access customer data or use it to train models, and the company said the new service is compliant with the Health Insurance Portability and Accountability Act, or HIPAA.
Gupta said that as a patient, interacting with the health-care system can feel like a very fragmented and challenging experience, so she is excited to see how clinicians can ultimately leverage Google’s new tools to create a fuller picture.
“To me, connecting the dots from the patient perspective has long been health care’s journey, but it’s hard,” Gupta said. “Now, we are at a point where AI is being helpful in these very practical use cases.”
Xpeng CEO He Xiaopeng speaks to reporters at the electric carmaker’s stand at the IAA auto show in Munich, Germany on September 8, 2025.
Arjun Kharpal | CNBC
Germany this week played host to one of the world’s biggest auto shows — but in the heartland of Europe’s auto industry, it was buzzy Chinese electric car companies looking to outshine some of the region’s biggest brands on their home turf.
The IAA Mobility conference in Munich was packed full of companies with huge stands showing off their latest cars and technology. Among some of the biggest displays were those from Chinese electric car companies, underscoring their ambitions to expand beyond China.
Europe has become a focal point for the Asian firms. It’s a market where the traditional automakers are seen to be lagging in the development of electric vehicles, even as they ramp up releases of new cars. At the same time, Tesla, which was for so long seen as the electric vehicle market leader, has seen sales decline in the region.
Despite Chinese EV makers facing tariffs from the European Union, players from the world’s second-largest economy have responded to the ramping up of competition by setting aggressive sales and expansion targets.
“The current growth of Xpeng globally is faster than we have expected,” He Xiaopeng, the CEO of Xpeng told CNBC in an interview this week.
Aggressive expansion plans
Chinese carmakers who spoke to CNBC at the IAA show signaled their ambitious expansion plans.
Xpeng’s He said in an interview that the company is looking to launch its mass-market Mona series in Europe next year. In China, Xpeng’s Mona cars start at the equivalent of just under $17,000. Bringing this to Europe would add some serious price competition.
Meanwhile, Guangzhou Automobile Group (GAC) is targeting rapid growth of its sales in Europe. Wei Haigang, president of GAC International, told CNBC that the company aims to sell around 3,000 cars in Europe this year and at least 50,000 units by 2027. GAC also announced plans to bring two EVs — the Aion V and Aion UT — to Europe. Leapmotor was also in attendance with their own stand.
There are signs that Chinese players have made early in roads into Europe. The market share of Chinese car brands in Europe nearly doubled in the first half of the year versus the same period in 2024, though it still remains low at just over 5%, according to Jato Dynamics.
“The significant presence of Chinese electric vehicle (EV) makers at the IAA Mobility, signals their growing ambitions and confidence in the European market,” Murtuza Ali, senior analyst at Counterpoint Research, told CNBC.
Tech and gadgets in focus
Many of the Chinese car firms have positioned themselves as technology companies, much like Tesla, and their cars highlight that.
Many of the electric vehicles have big screens equipped with flashy interfaces and voice assistants. And in a bid to lure buyers, some companies have included additional gadgets.
For example, GAC’s Aion V sported a refrigerator as well as a massage function as part of the seating.
The Aion V is one of the cars GAC is launching in Europe as it looks to expand its presence in the region. The Aion V is on display at the company’s stand at the IAA Mobility auto show in Munich, Germany on September 9, 2025.
Arjun Kharpal | CNBC
This is one way that the Chinese players sought to differentiate themselves from legacy brands.
“The chances of success for Chinese automakers are strong, especially as they have an edge in terms of affordability, battery technology, and production scale,” Counterpoint’s Ali said.
Europe’s carmakers push back
Legacy carmakers sought to flex their own muscles at the IAA with Volskwagen, BMW and Mercedes having among the biggest stands at the show. Mercedes in particular had advertising displayed all across the front entrance of the event.
BMW, like the Chinese players, had a big focus on technology by talking up its so-called “superbrain architecture,” which replaces hardware with a centralized computer system. BMW, which introduced the iX3 at the event, and chipmaker Qualcomm also announced assisted driving software that the two companies co-developed.
Volkswagen and French auto firm Renault also showed off some new electric cars.
Regardless of the product blitz, there are still concerns that European companies are not moving fast enough. BMW’s new iX3 is based on the electric vehicle platform it first debuted two years ago. Meanwhile, Chinese EV makers have been quick in bringing out and launching newer models.
“A commitment to legacy structures and incrementalism has slowed its ability to build and leverage a robust EV ecosystem, leaving it behind fast moving rivals,” Tammy Madsen, professor of management at the Leavey School of Business at Santa Clara University, said of BMW.
While European autos have a strong brand history and their CEOs acknowledged and welcomed the competition this week in interviews with CNBC, the Chinese are not letting up.
“Europe’s automakers still hold significant brand value and legacy. The challenge for them lies in achieving production at scale and adopting new technologies faster,” Counterpoint’s Ali said.
“The Chinese surely are not waiting for anyone to catch-up and are making significant gains.”
OpenAI on Friday introduced a new program, dubbed the “OpenAI Grove,” for early tech entrepreneurs looking to build with artificial intelligence, and applications are already open.
Unlike OpenAI’s Pioneer Program, which launched in April, Grove is aimed towards individuals at the very nascent phases of their company development, from the pre-idea to pre-seed stage.
For five weeks, participants will receive mentoring from OpenAI technical leaders, early access to new tools and models, and in-person workshops, located in the company’s San Francisco headquarters.
Roughly 15 members will join Grove’s first cohort, which will run from Oct. 20 to Nov. 21, 2025. Applicants will have until Sept. 24 to submit an entry form.
CNBC has reached out to OpenAI for comment on the program.
Following the program, Grove participants will be able to continue working internally with the ChatGPT maker, which was recent valued $500 billion.
Nurturing these budding AI companies is just a small chip in the recent massive investments into AI firms, which ate up an impressive 71% of U.S. venture funding in 2025, up from 45% last year, according to an analysis from J.P. Morgan.
AI startups raised $104.3 billion in the U.S. in the first half of this year, and currently over 1,300 AI startups have valuations of over $100 million, according to CB Insights.
The co-founder and CEO of sales and customer service management software company Salesforce is well aware that investors are betting big on Palantir, which offers data management software to businesses and government agencies.
“Oh my gosh. I am so inspired by that company,” Benioff told CNBC’s Morgan Brennan in a Tuesday interview at Goldman Sachs‘ Communacopia+Technology conference in San Francisco. “I mean, not just because they have 100 times, you know, multiple on their revenue, which I would love to have that too. Maybe it’ll have 1000 times on their revenue soon.”
Salesforce, a component of the Dow Jones Industrial Average, remains 10 times larger than Palantir by revenue, with over $10 billion in revenue during the latest quarter. But Palantir is growing 48%, compared with 10% for Salesforce.
Benioff added that Palantir’s prices are “the most expensive enterprise software I’ve ever seen.”
“Maybe I’m not charging enough,” he said.
Read more CNBC tech news
It wasn’t Benioff’s first time talking about Palantir. Last week, Benioff referenced Palantir’s “extraordinary” prices in an interview with CNBC’s Jim Cramer, saying Salesforce offers a “very competitive product at a much lower cost.”
The next day, TBPN podcast hosts John Coogan and Jordi Hays asked for a response from Alex Karp, Palantir’s co-founder and CEO.
“We are very focused on value creation, and we ask to be modestly compensated for that value,” Karp said.
The companies sometimes compete for government deals, and Benioff touted a recent win over Palantir for a U.S. Army contract.
Palantir started in 2003, four years after Salesforce. But while Salesforce went public in 2004, Palantir arrived on the New York Stock Exchange in 2020.
Palantir’s market capitalization stands at $406 billion, while Salesforce is worth $231 billion. And as one of the most frequently traded stocks on Robinhood, Palantir is popular with retail investors.
Salesforce shares are down 27% this year, the worst performance in large-cap tech.